The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
Michael Kriegbaum SkjødtM T ErnstSara KhalidC LibanatiC CooperAntonella DelmestriKatrine Hass RubinM K JavaidDaniel Martínez-LagunaE TothD Prieto-AlhambraBo AbrahamsenPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2021)
A significant treatment gap among patients sustaining a major osteoporotic fracture was present throughout our analysis, and including hospital-administered AOM did not significantly improve the treatment gap assessment. Improved secondary fracture prevention is urgently needed.